MD Magazine: Condition Center: Spondyloarthritis Copyright (c) 2017 Intellisphere, LLC. All rights reserved. http://www.mdmag.com/conditions/spondyloarthritis/rss Spondyloarthritis en-us Thu, 23 Jan 2020 22:32:04 +0000 Rheumatoid Medicine Trends Move to a Different Beat https://www.mdmag.com/medical-news/rheumatoid-medicine-moves-to-a-different-beat https://www.mdmag.com/medical-news/rheumatoid-medicine-moves-to-a-different-beat Mon, 16 Dec 2019 11:48:00 +0000 James Mossell, DO: Meeting Needs in Rheumatology https://www.mdmag.com/medical-news/james-mossell-do-meeting-needs-in-rheumatology https://www.mdmag.com/medical-news/james-mossell-do-meeting-needs-in-rheumatology Wed, 11 Dec 2019 22:49:00 +0000 Philip Mease, MD: Treatment Options for Psoriatic Arthritis https://www.mdmag.com/conference-coverage/acr-2019/philip-mease-md-treatment-options-psoriatic-arthritis https://www.mdmag.com/conference-coverage/acr-2019/philip-mease-md-treatment-options-psoriatic-arthritis Thu, 14 Nov 2019 19:55:00 +0000 Trial Data Indicates Golimumab Improves Quality of Life in Psoriatic Arthritis https://www.mdmag.com/conference-coverage/acr-2019/trial-data-golimumab-quality-of-life-psoriatic-arthritis https://www.mdmag.com/conference-coverage/acr-2019/trial-data-golimumab-quality-of-life-psoriatic-arthritis Thu, 14 Nov 2019 17:53:00 +0000 Upadacitinib Shows Promise for Ankylosing Spondylitis in SELECT-AXIS 1 https://www.mdmag.com/conference-coverage/acr-2019/upadacitinib-shows-promise-treatment-ankylosing-spondylitis https://www.mdmag.com/conference-coverage/acr-2019/upadacitinib-shows-promise-treatment-ankylosing-spondylitis Wed, 13 Nov 2019 20:35:00 +0000 Philip Mease, MD: The Role of JAK Inhibitors in Psoriatic Arthritis https://www.mdmag.com/conference-coverage/acr-2019/jak-inhibitors-psoriatic-arthritis https://www.mdmag.com/conference-coverage/acr-2019/jak-inhibitors-psoriatic-arthritis Wed, 13 Nov 2019 15:52:00 +0000 Ixekizumab Outperforms Adalimumab in Head-to-Head Psoriatic Arthritis Trial https://www.mdmag.com/conference-coverage/acr-2019/ixekizumab-outperforms-adalimumab-psoriatic-arthritis-trial-taltz-humira https://www.mdmag.com/conference-coverage/acr-2019/ixekizumab-outperforms-adalimumab-psoriatic-arthritis-trial-taltz-humira Wed, 13 Nov 2019 00:53:00 +0000 Atul Deodhar, MD: Treatment Disparities in nr-axSpA and Ankylosing Spondylitis https://www.mdmag.com/conference-coverage/acr-2019/treatment-disparities-nr-axspa-ankylosing-spondylitis https://www.mdmag.com/conference-coverage/acr-2019/treatment-disparities-nr-axspa-ankylosing-spondylitis Tue, 12 Nov 2019 19:29:00 +0000 Philip Mease, MD: Guselkumab an Effective Treatment for Psoriatic Arthritis https://www.mdmag.com/conference-coverage/acr-2019/philip-mease-guselkumab-effective-psoriatic-arthritis https://www.mdmag.com/conference-coverage/acr-2019/philip-mease-guselkumab-effective-psoriatic-arthritis Tue, 12 Nov 2019 16:06:00 +0000 Elaine Husni, MD: Choosing Between Treatments in Psoriatic Arthritis https://www.mdmag.com/conference-coverage/acr-2019/choosing-treatments-psoriatic-arthritis https://www.mdmag.com/conference-coverage/acr-2019/choosing-treatments-psoriatic-arthritis Mon, 11 Nov 2019 18:04:00 +0000 PREVENT Trial Data Supports Use of Secukinumab for Spondyloarthritis https://www.mdmag.com/medical-news/secukinumab-non-radiographic-axial-spondyloarthritis https://www.mdmag.com/medical-news/secukinumab-non-radiographic-axial-spondyloarthritis Wed, 02 Oct 2019 14:17:00 +0000 Tofacitinib Improves Quality of Life, Skin Symptoms In Psoriatic Arthritis https://www.mdmag.com/conference-coverage/ccr-west-2019/tofacitinib-quality-life-skin-symptoms-psoriatic-arthritis https://www.mdmag.com/conference-coverage/ccr-west-2019/tofacitinib-quality-life-skin-symptoms-psoriatic-arthritis Mon, 30 Sep 2019 16:04:00 +0000 Filgotinib Could Be Effective for Treating Ankylosing Spondylitis https://www.mdmag.com/conference-coverage/ccr-west-2019/filgotinib-could-be-effective-for-treating-ankylosing-spondylitis https://www.mdmag.com/conference-coverage/ccr-west-2019/filgotinib-could-be-effective-for-treating-ankylosing-spondylitis Sat, 28 Sep 2019 23:17:00 +0000 Time to Pain Improvement with Tofacitinib in Psoriatic Arthritis https://www.mdmag.com/conference-coverage/ccr-west-2019/time-to-pain-improvement-with-tofacitinib-in-psoriatic-arthritis https://www.mdmag.com/conference-coverage/ccr-west-2019/time-to-pain-improvement-with-tofacitinib-in-psoriatic-arthritis Fri, 27 Sep 2019 19:19:00 +0000 Janet Pope, MD: Rheumatoid Areas in Most Need of Research https://www.mdmag.com/conference-coverage/ccr-west-2019/janet-pope-md-rheumatoid-areas-in-most-need-of-research https://www.mdmag.com/conference-coverage/ccr-west-2019/janet-pope-md-rheumatoid-areas-in-most-need-of-research Thu, 26 Sep 2019 22:17:00 +0000 Margaret Bobonich, DNP, DCNP: Using Biologic Therapies for Psoriasis, Atopic Dermatitis https://www.mdmag.com/medical-news/margaret-bobonich-dnp-dcnp-biologic-therapies-psoriasis-atopic-dermatitis https://www.mdmag.com/medical-news/margaret-bobonich-dnp-dcnp-biologic-therapies-psoriasis-atopic-dermatitis Tue, 24 Sep 2019 09:00:00 +0000 Janssen Submits Guselkumab sBLA for Active Psoriatic Arthritis https://www.mdmag.com/medical-news/janssen-guselkumab-sbla-active-psoriatic-arthritis https://www.mdmag.com/medical-news/janssen-guselkumab-sbla-active-psoriatic-arthritis Thu, 19 Sep 2019 15:37:00 +0000 FDA Approves Ixekizumab to Treat Active Ankylosing Spondylitis https://www.mdmag.com/medical-news/fda-approves-ixekizumab-treat-active-ankylosing-spondylitis https://www.mdmag.com/medical-news/fda-approves-ixekizumab-treat-active-ankylosing-spondylitis Mon, 26 Aug 2019 13:17:00 +0000 New Ankylosing Spondylitis, Axial Spondyloarthritis Guidelines Released https://www.mdmag.com/medical-news/new-ankylosing-spondylitis-axial-spondyloarthritis-guidelines https://www.mdmag.com/medical-news/new-ankylosing-spondylitis-axial-spondyloarthritis-guidelines Fri, 23 Aug 2019 11:00:00 +0000 Increase in Blood Clot and Death Risk Spark FDA Warnings for Tofacitinib https://www.mdmag.com/medical-news/blood-clot-death-fda-warnings-tofacitinib https://www.mdmag.com/medical-news/blood-clot-death-fda-warnings-tofacitinib Tue, 06 Aug 2019 16:28:00 +0000 Filgotinib Drives 12-Week Benefit for Rheumatoid Arthritis https://www.mdmag.com/medical-news/filgotinib-for-treatment-of-rheumatoid-arthritis https://www.mdmag.com/medical-news/filgotinib-for-treatment-of-rheumatoid-arthritis Tue, 23 Jul 2019 15:00:00 +0000 Guselkumab Effective for Psoriatic Arthritis Symptoms https://www.mdmag.com/medical-news/guselkumab-effective-for-psoriatic-arthritis-symptoms https://www.mdmag.com/medical-news/guselkumab-effective-for-psoriatic-arthritis-symptoms Fri, 21 Jun 2019 09:00:00 +0000 Apremilast Helps Achieve Low Psoriatic Arthritis Disease Activity or Remission https://www.mdmag.com/medical-news/apremilast-helps-achieve-low-psoriatic-arthritis-disease-activity-or-remission https://www.mdmag.com/medical-news/apremilast-helps-achieve-low-psoriatic-arthritis-disease-activity-or-remission Wed, 19 Jun 2019 13:00:00 +0000 Infliximab, Golimumab Both Effective for Ankylosing Spondylitis https://www.mdmag.com/medical-news/infliximab-golimumab-effective-ankylosing-spondylitis https://www.mdmag.com/medical-news/infliximab-golimumab-effective-ankylosing-spondylitis Tue, 18 Jun 2019 09:00:00 +0000 Tildrakizumab for Psoriatic Arthritis Shows Promise in Phase 2 Results https://www.mdmag.com/medical-news/tildrakizumab-psoriatic-arthritis-shows-promise-phase-2-results https://www.mdmag.com/medical-news/tildrakizumab-psoriatic-arthritis-shows-promise-phase-2-results Mon, 17 Jun 2019 19:46:00 +0000 Cosentyx Stops or Lessens Psoriatic Arthritis Symptoms, Studies Show https://www.mdmag.com/medical-news/cosentyx-stops-or-lessens-psoriatic-arthritis-symptoms-studies-show https://www.mdmag.com/medical-news/cosentyx-stops-or-lessens-psoriatic-arthritis-symptoms-studies-show Sat, 15 Jun 2019 09:00:00 +0000 Ixekizumab Shows Strength Against Adalimumab in SPIRIT-H2H https://www.mdmag.com/medical-news/ixekizumab-shows-strength-against-adalimumab-spirit-h2h https://www.mdmag.com/medical-news/ixekizumab-shows-strength-against-adalimumab-spirit-h2h Fri, 14 Jun 2019 11:00:00 +0000 Brian Toy, MD: Risk Factors for Uveitis https://www.mdmag.com/conference-coverage/arvo-2019/brian-toy-md-risk-factors-uveitis https://www.mdmag.com/conference-coverage/arvo-2019/brian-toy-md-risk-factors-uveitis Fri, 10 May 2019 15:00:00 +0000 FDA Approves Risankizumab for Plaque Psoriasis https://www.mdmag.com/medical-news/fda-approves-risankizumab-for-plaque-psoriasis https://www.mdmag.com/medical-news/fda-approves-risankizumab-for-plaque-psoriasis Wed, 24 Apr 2019 13:53:00 +0000 Phase 3 Trial of Ixekizumab Reports Positive Results https://www.mdmag.com/medical-news/phase-3-trial-ixekizumab-reports-positive-results https://www.mdmag.com/medical-news/phase-3-trial-ixekizumab-reports-positive-results Mon, 22 Apr 2019 19:45:00 +0000